Speakman CT - Search Results

1

Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor.

Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, Bingham SA. Loktionov A, et al. Among authors: speakman ct. Carcinogenesis. 2001 Jul;22(7):1053-60. doi: 10.1093/carcin/22.7.1053. Carcinogenesis. 2001. PMID: 11408349

2

Plasminogen activator inhibitor-1 gene polymorphism and colorectal cancer risk and prognosis.

Loktionov A, Watson MA, Stebbings WS, Speakman CT, Bingham SA. Loktionov A, et al. Among authors: speakman ct. Cancer Lett. 2003 Jan 28;189(2):189-96. doi: 10.1016/s0304-3835(02)00556-6. Cancer Lett. 2003. PMID: 12490312

3

NQO1 and mEH exon 4 (mEH4) gene polymorphisms, smoking and colorectal cancer risk.

Mitrou P, Watson M, Bingham S, Stebbings WS, Speakman CT, Loktionov A. Mitrou P, et al. Among authors: speakman ct. IARC Sci Publ. 2002;156:495-7. IARC Sci Publ. 2002. PMID: 12484241 No abstract available.

4

Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis.

Watson MA, Gay L, Stebbings WS, Speakman CT, Bingham SA, Loktionov A. Watson MA, et al. Among authors: speakman ct. Clin Sci (Lond). 2003 May;104(5):537-45. doi: 10.1042/CS20020329. Clin Sci (Lond). 2003. PMID: 12529167

5

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators. Atkin WS, et al. Lancet. 2010 May 8;375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X. Epub 2010 Apr 27. Lancet. 2010. PMID: 20430429 Free article. Clinical Trial.

6

K-ras mutations, rectal crypt cells proliferation, and meat consumption in patients with left-sided colorectal carcinoma.

O'Brien H, Matthew JA, Gee JM, Watson M, Rhodes M, Speakman CT, Stebbings WS, Kennedy HJ, Johnson IT. O'Brien H, et al. Among authors: speakman ct. Eur J Cancer Prev. 2000 Feb;9(1):41-7. doi: 10.1097/00008469-200002000-00006. Eur J Cancer Prev. 2000. PMID: 10777009

7

Anti-inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease.

Morris CR, Harvey IM, Stebbings WS, Speakman CT, Kennedy HJ, Hart AR. Morris CR, et al. Among authors: speakman ct. Br J Surg. 2003 Oct;90(10):1267-72. doi: 10.1002/bjs.4221. Br J Surg. 2003. PMID: 14515298

8

Do calcium channel blockers and antimuscarinics protect against perforated colonic diverticular disease? A case control study.

Morris CR, Harvey IM, Stebbings WS, Speakman CT, Kennedy HJ, Hart AR. Morris CR, et al. Among authors: speakman ct. Gut. 2003 Dec;52(12):1734-7. doi: 10.1136/gut.52.12.1734. Gut. 2003. PMID: 14633952 Free PMC article.

9

Epidemiology of perforated colonic diverticular disease.

Morris CR, Harvey IM, Stebbings WS, Speakman CT, Kennedy HJ, Hart AR. Morris CR, et al. Among authors: speakman ct. Postgrad Med J. 2002 Nov;78(925):654-8. doi: 10.1136/pmj.78.925.654. Postgrad Med J. 2002. PMID: 12496319 Free PMC article. Review.

10

The colon-selective spasmolytic otilonium bromide inhibits muscarinic M(3) receptor-coupled calcium signals in isolated human colonic crypts.

Lindqvist S, Hernon J, Sharp P, Johns N, Addison S, Watson M, Tighe R, Greer S, Mackay J, Rhodes M, Lewis M, Stebbings W, Speakman C, Evangelista S, Johnson I, Williams M. Lindqvist S, et al. Br J Pharmacol. 2002 Dec;137(7):1134-42. doi: 10.1038/sj.bjp.0704942. Br J Pharmacol. 2002. PMID: 12429587 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters